Weigel NL - Search Results

1

1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1.

Blutt SE, Allegretto EA, Pike JW, Weigel NL. Blutt SE, et al. Among authors: weigel nl. Endocrinology. 1997 Apr;138(4):1491-7. doi: 10.1210/endo.138.4.5063. Endocrinology. 1997. PMID: 9075707

2

p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells.

Polek TC, Stewart LV, Ryu EJ, Cohen MB, Allegretto EA, Weigel NL. Polek TC, et al. Among authors: weigel nl. Endocrinology. 2003 Jan;144(1):50-60. doi: 10.1210/en.2001-210109. Endocrinology. 2003. PMID: 12488329

3

Vitamin D and prostate cancer.

Blutt SE, Weigel NL. Blutt SE, et al. Among authors: weigel nl. Proc Soc Exp Biol Med. 1999 Jun;221(2):89-98. doi: 10.1046/j.1525-1373.1999.d01-60.x. Proc Soc Exp Biol Med. 1999. PMID: 10352118 Review.

4

Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2.

Blutt SE, McDonnell TJ, Polek TC, Weigel NL. Blutt SE, et al. Among authors: weigel nl. Endocrinology. 2000 Jan;141(1):10-7. doi: 10.1210/endo.141.1.7289. Endocrinology. 2000. PMID: 10614618

5

A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice.

Blutt SE, Polek TC, Stewart LV, Kattan MW, Weigel NL. Blutt SE, et al. Among authors: weigel nl. Cancer Res. 2000 Feb 15;60(4):779-82. Cancer Res. 2000. PMID: 10706079

6

Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium.

Polek TC, Murthy S, Blutt SE, Boehm MF, Zou A, Weigel NL, Allegretto EA. Polek TC, et al. Among authors: weigel nl. Prostate. 2001 Nov 1;49(3):224-33. doi: 10.1002/pros.1138. Prostate. 2001. PMID: 11746268

7

1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.

Rohan JN, Weigel NL. Rohan JN, et al. Among authors: weigel nl. Endocrinology. 2009 May;150(5):2046-54. doi: 10.1210/en.2008-1395. Epub 2009 Jan 22. Endocrinology. 2009. PMID: 19164469 Free PMC article.

8

1,25-dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the human vitamin D receptor: site-directed mutagenesis of this residue promotes alternative phosphorylation.

Hilliard GM 4th, Cook RG, Weigel NL, Pike JW. Hilliard GM 4th, et al. Among authors: weigel nl. Biochemistry. 1994 Apr 12;33(14):4300-11. doi: 10.1021/bi00180a026. Biochemistry. 1994. PMID: 8155647

9

1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion.

Washington MN, Weigel NL. Washington MN, et al. Among authors: weigel nl. Endocrinology. 2010 Apr;151(4):1409-17. doi: 10.1210/en.2009-0991. Epub 2010 Feb 10. Endocrinology. 2010. PMID: 20147525 Free PMC article.

10

Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3.

Murthy S, Marcelli M, Weigel NL. Murthy S, et al. Among authors: weigel nl. Prostate. 2003 Sep 1;56(4):293-304. doi: 10.1002/pros.10261. Prostate. 2003. PMID: 12858358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters